COVID-19 Vaccine Packaging And Delivery Devices

COVID-19 Vaccine Packaging And Delivery Devices Market Outlook

The global COVID-19 vaccine packaging and delivery devices market is anticipated to reach USD 15.2 billion by 2035, growing at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2035. The significant growth of this market can be attributed to the increasing global immunization programs, the urgent need for efficient vaccine distribution amidst the pandemic, and the escalating investments in healthcare infrastructure. The rising demand for safe and effective vaccine delivery mechanisms coupled with advancements in packaging technologies are also expected to propel market growth. Furthermore, the introduction of innovative packaging solutions that enhance the stability and shelf-life of vaccines will play a crucial role in driving the market forward. The urgency of COVID-19 vaccination has necessitated the development of specialized delivery devices, which are integral to ensuring that vaccines reach the target population in optimal condition.

Growth Factor of the Market

The growth of the COVID-19 vaccine packaging and delivery devices market is primarily driven by several key factors. Firstly, the unprecedented global health crisis instigated by the COVID-19 pandemic has highlighted the necessity for efficient distribution and delivery mechanisms for vaccines. As governments and health organizations strive to vaccinate vast segments of the population quickly, the demand for effective packaging solutions has surged significantly. Secondly, advancements in technology have led to the development of innovative packaging materials that not only enhance the safety and efficacy of vaccines but also improve logistical efficiency during transportation. Thirdly, the increasing collaboration between pharmaceutical companies and packaging manufacturers has resulted in tailored solutions that meet the specific needs of vaccine distribution. Additionally, the rise of e-commerce and online pharmacies has created new channels for vaccine delivery, further stimulating demand for sophisticated delivery devices. Finally, the growing awareness regarding the importance of immunization against infectious diseases is encouraging investment in vaccine development and distribution, thereby bolstering the market.

Key Highlights of the Market

• The market is projected to grow at a CAGR of 8.6% from 2025 to 2035.
• Innovative packaging solutions are being developed to enhance vaccine stability.
• Increased partnership between pharmaceutical and packaging companies is a key trend.
• Expansion of e-commerce is creating new opportunities for vaccine delivery.
• Growing global immunization initiatives provide robust market support.

By Product Type

Vials:

The vials segment represents a significant portion of the COVID-19 vaccine packaging and delivery devices market. Vials are essential for containing and preserving the integrity of vaccines during storage and transportation. They are designed to be airtight and protect the vaccine from contamination. The increasing volume of vaccine production necessitates the use of vials in larger quantities, ensuring that each dose is delivered effectively. The versatility of vials, available in various sizes and materials, allows for flexibility in vaccine formulation, whether liquid or freeze-dried. Moreover, advancements in vial design, such as the introduction of pre-filled vials, are streamlining the vaccination process and reducing the risk of dosage errors, thereby enhancing patient safety and compliance.

Syringes:

Syringes are pivotal in the administration of vaccines and account for a substantial share of the market. The widespread use of disposable syringes has significantly improved hygiene and safety during vaccination campaigns. The convenience of pre-filled syringes also contributes to their popularity, as they minimize the risk of cross-contamination and ensure accurate dosing. The syringes segment is experiencing growth due to the rising demand for self-administration devices, which allow individuals to receive their vaccinations conveniently. Furthermore, innovations such as needle-free syringes are gaining traction, offering pain-free delivery options that enhance patient acceptance and adherence to vaccination schedules.

Ampoules:

Ampoules serve as an alternative to vials and syringes and are becoming increasingly popular in the vaccine packaging market. Their hermetically sealed design ensures the sterility of the vaccine, making them ideal for sensitive formulations. The use of ampoules is particularly relevant for vaccines that require protection from light and moisture. They are often used in clinical settings where the immediate use of the vaccine is expected, thereby reducing the risk of waste. The ampoules segment is projected to grow as the demand for specialized packaging solutions for various vaccine types rises, particularly for those requiring unique storage and handling conditions.

Cartridges:

The cartridges segment is witnessing growth as they are integral to the delivery of certain types of vaccines, especially in pen delivery systems. Cartridges are designed for easy integration with injection devices, enabling accurate dosing for both healthcare professionals and patients alike. The rise in the development of pen devices for self-administration is driving the cartridges segment, as they offer a user-friendly solution for vaccination. The convenience of using cartridges aligns with the global trend towards patient-centric healthcare, making vaccinations easier to administer and encouraging higher vaccination rates. As manufacturers focus on creating more efficient and ergonomic delivery systems, the cartridges segment is expected to see substantial growth in the coming years.

Prefilled Pens:

Prefilled pens are emerging as a highly efficient method for vaccine delivery, particularly for self-administration. They offer convenience and reduce the risk of dosage errors, making them an attractive option for public health campaigns. The design of prefilled pens allows for easy and safe vaccine administration without the need for additional syringes, which is particularly beneficial in remote or underserved areas. The growth of the prefilled pens market is being driven by the increasing need for innovative solutions that improve patient compliance and experience. Moreover, the integration of smart technologies, such as tracking and reminder systems, is enhancing the functionality of these devices, further propelling their adoption in vaccination programs.

By Application

Hospitals:

Hospitals are one of the primary applications for COVID-19 vaccine packaging and delivery devices. With their extensive infrastructure and resources, hospitals play a critical role in administering vaccinations, especially during mass immunization campaigns. The significant demand for packaging and delivery devices in hospitals stems from the high volume of vaccinations that occur in these settings. Hospitals require robust and reliable packaging solutions that ensure the integrity and sterility of vaccines until administration. Additionally, hospitals are increasingly adopting advanced technologies that streamline the vaccination process, thereby enhancing overall efficiency and patient safety.

Clinics:

Clinics serve as essential points of care for vaccinations, particularly in community settings where access to healthcare is crucial. The demand for vaccine packaging and delivery devices in clinics is driven by the need for smaller-scale, yet efficient delivery mechanisms that cater specifically to individual patient needs. Clinics often require flexible and adaptable solutions that can handle various vaccine types and dosing schedules. The increasing emphasis on preventive healthcare is encouraging more clinics to engage in vaccination initiatives, thus driving the demand for effective packaging and delivery solutions tailored for their specific operational dynamics.

Vaccination Centers:

Vaccination centers have become critical hubs for vaccine distribution during the COVID-19 pandemic. These centers are designed to handle large volumes of vaccinations efficiently and require packaging and delivery devices that facilitate high-throughput vaccination. The use of specialized packaging solutions ensures that vaccines remain viable during storage and transport, which is essential in a high-demand environment. Vaccination centers are also increasingly utilizing technology-driven solutions to streamline the vaccination process, including digital tracking of vaccine inventories and patient records. The growth of vaccination centers is expected to continue, thus propelling the demand for improved packaging and delivery devices to support these operations.

Retail Pharmacies:

Retail pharmacies have emerged as important players in the COVID-19 vaccination landscape, offering accessible vaccination services to the public. The packaging and delivery devices used in retail pharmacies must cater to a diverse customer base while ensuring safety and efficiency. The adoption of pre-filled syringes and other user-friendly delivery systems is prevalent in retail settings, where convenience and speed are paramount. As more consumers turn to pharmacies for their vaccination needs, the demand for innovative packaging solutions that ensure the safe and effective delivery of vaccines will grow. Retail pharmacies are also key partners in public health initiatives, further solidifying their role in the vaccine distribution network.

Others:

This category includes various other applications for vaccine packaging and delivery devices, such as non-traditional healthcare settings and mobile vaccination units. These applications are gaining traction as the emphasis on flexible and accessible vaccination options rises. Innovative solutions are being developed to cater to unique environments, such as rural outreach programs and temporary vaccination clinics. The need for adaptable and portable packaging solutions is increasing, as they allow for the effective delivery of vaccines in diverse situations. As vaccination efforts expand beyond traditional healthcare facilities, the need for specialized packaging and delivery devices tailored to these unique contexts is expected to rise dramatically.

By Distribution Channel

Direct Sales:

Direct sales play a pivotal role in the distribution of COVID-19 vaccine packaging and delivery devices. In this model, manufacturers sell their products directly to healthcare facilities, clinics, and vaccination centers, enabling them to maintain better control over pricing and product availability. The direct sales approach allows manufacturers to establish strong relationships with healthcare providers, ensuring that they meet the specific needs of their clients. As the demand for vaccines and related packaging solutions continues to grow, the direct sales channel will likely remain a vital route for ensuring that healthcare facilities have immediate access to the necessary supplies for efficient vaccination campaigns.

Distributor Sales:

Distributor sales have become increasingly important for the COVID-19 vaccine packaging and delivery devices market as they provide a broader reach for manufacturers. Distributors serve as intermediaries, enabling manufacturers to access various markets and clients without the complexities of direct sales. The efficiency offered by distributors in the supply chain can lead to faster delivery times and improved inventory management for healthcare providers. As vaccination campaigns ramp up, distributors are essential for ensuring that packaging and delivery devices are readily available across multiple regions and healthcare settings, ultimately facilitating a swift and effective vaccination process.

By Material Type

Glass:

Glass is a widely used material in vaccine packaging due to its excellent barrier properties and ability to maintain the stability of the contents. Glass vials and ampoules are preferred for their inert nature, meaning they do not react chemically with the vaccine, thus ensuring the preservation of its efficacy. The transparency of glass also allows for easy visual inspection of the product, which is crucial for quality control in vaccine administration. However, glass can be fragile, necessitating careful handling during transportation and storage. Innovations in glass packaging, such as the development of break-resistant designs, are helping to address these challenges while maintaining the benefits of glass as a packaging material.

Plastic:

Plastic is increasingly being utilized in the production of vaccine packaging and delivery devices due to its versatility, lightweight properties, and resistance to breakage. Plastic syringes, cartridges, and vials are commonly used in various healthcare settings due to their convenience and safety features. The ability to manufacture plastic products in large quantities at reduced costs further drives their popularity in the COVID-19 vaccine market. Moreover, advancements in plastic technology have led to the development of high-performance polymers that offer better barrier properties than traditional plastics, ensuring the stability of vaccines during storage and transport. The rising demand for environmentally friendly packaging solutions is also prompting manufacturers to explore recycled and biodegradable plastic materials.

Metal:

Metal packaging, particularly aluminum, is gaining attention as a viable option for vaccine delivery devices. Metal containers offer robustness and protection against environmental factors, thus ensuring the integrity of the vaccine. The use of metal in packaging systems, such as prefilled pens, combines durability with advanced technology, providing an efficient means of delivering vaccines. The appeal of metal packaging lies in its recyclability, making it a sustainable choice for the growing demand for eco-friendly solutions in the healthcare sector. As manufacturers focus on creating innovative metal packaging designs, the potential for this material in vaccine delivery applications is expanding significantly.

Rubber:

Rubber plays a crucial role in the sealing of vaccine containers, particularly in the form of rubber stoppers for vials and syringes. Rubber stoppers provide a secure seal that protects the vaccine from contamination while allowing for ease of access during administration. The flexibility and elastic properties of rubber make it an ideal choice for maintaining the integrity of vaccine packaging. Additionally, advancements in rubber formulations are enhancing the compatibility of rubber with various vaccine types, minimizing the risk of interactions that could compromise vaccine efficacy. The demand for high-quality rubber components is anticipated to grow as the global vaccination efforts continue to expand.

By Region

In North America, the COVID-19 vaccine packaging and delivery devices market is poised to witness substantial growth, driven by the region's robust healthcare infrastructure and the high rate of vaccine administration. The increasing investments in healthcare technology and logistics are further enhancing the distribution of vaccines across this region. The market is expected to reach USD 5.0 billion by 2035, with a CAGR of 9.0% during the forecast period. The United States, in particular, leads the charge in vaccine development and distribution, necessitating advanced packaging and delivery solutions to cater to the vast network of healthcare providers and vaccination centers.

Europe is also a significant player in the COVID-19 vaccine packaging and delivery devices market, with the region projected to reach USD 4.0 billion by 2035. The EU's coordinated vaccination efforts, combined with stringent regulatory standards for vaccine packaging, are driving demand for high-quality delivery devices. The surge in vaccination campaigns across countries such as Germany, France, and the UK is reinforcing the need for innovative and efficient packaging solutions. Similarly, the rapid growth of vaccination centers in urban areas is prompting an increased demand for diverse packaging options that ensure the safety and efficacy of vaccines during distribution. As a result, Europe's market is expected to grow at a CAGR of 8.0% during the forecast period.

Opportunities

One of the most significant opportunities in the COVID-19 vaccine packaging and delivery devices market lies in technological advancements. As healthcare continues to evolve, there is a growing demand for smart packaging solutions that enhance the tracking and monitoring of vaccines throughout the supply chain. Integrating IoT technology with packaging devices can provide real-time data on temperature, humidity, and handling conditions, ensuring that vaccines are stored and transported within their specified parameters. Such innovations will not only improve the overall efficacy of vaccines but also instill greater confidence in healthcare systems and the public regarding vaccine safety. Manufacturers that invest in developing intelligent packaging solutions are likely to gain a competitive edge and capture a larger market share.

Another opportunity arises from the increasing emphasis on sustainability within the healthcare sector. As environmental concerns gain prominence, there is a growing demand for eco-friendly packaging solutions that minimize waste and reduce the carbon footprint associated with vaccine distribution. Manufacturers are likely to benefit from exploring biodegradable materials and recyclable packaging options that align with global sustainability goals. Collaborating with environmental organizations and implementing sustainable practices in the production of vaccine packaging can enhance brand reputation while meeting the needs of a socially conscious consumer base. This shift towards greener practices presents a unique opportunity for companies looking to differentiate themselves in the competitive landscape of vaccine packaging and delivery devices.

Threats

Despite the promising growth in the COVID-19 vaccine packaging and delivery devices market, several threats could hinder its advancement. One significant threat is the potential for supply chain disruptions, which have become increasingly evident during the pandemic. Global shortages of raw materials and logistics challenges can adversely affect the availability of packaging devices, leading to delays in vaccine distribution. Such disruptions can undermine the efficiency of vaccination campaigns and may result in public mistrust regarding vaccine accessibility. Companies must proactively implement risk management strategies and diversify their supply chains to mitigate this threat and ensure consistent product availability in the market.

Another threat to this market is the rising competition among manufacturers. With an increasing number of players entering the vaccine packaging sector, maintaining a competitive edge has become increasingly challenging. Price wars, aggressive marketing strategies, and the introduction of innovative products can erode profit margins for established companies. To navigate this competitive landscape, manufacturers need to focus on differentiating their offerings through superior quality, customer service, and technological advancements. Failure to adapt to the dynamic market environment may result in decreased market share and financial instability, especially for smaller companies that lack the resources to compete effectively.

Competitor Outlook

• Gerresheimer AG
• Schott AG
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• Siemens Healthineers
• Medtronic plc
• 3M Company
• Cardinal Health, Inc.
• Fujifilm Diosynth Biotechnologies
• Polymer Solutions Group
• AptarGroup, Inc.
• Vetter Pharma-Fertigung GmbH & Co. KG
• Ypsomed AG
• Roxane Laboratories, Inc.
• Hoffmann-La Roche AG

The competitive landscape of the COVID-19 vaccine packaging and delivery devices market is characterized by a mix of established players and new entrants striving to innovate and capture market share. Leading companies such as Gerresheimer AG and Schott AG have long been at the forefront of the packaging sector, leveraging their extensive experience and technological expertise to develop advanced solutions tailored for vaccines. These companies have invested heavily in research and development to create packaging that not only meets regulatory standards but also addresses the unique challenges posed by COVID-19 vaccines, such as temperature sensitivity and stability. As a result, these market leaders are well-positioned to benefit from the increasing demand for reliable and innovative packaging solutions.

In addition to established companies, newer entrants are also making their mark on the industry by offering specialized packaging solutions that cater to specific market needs. For instance, companies like AptarGroup, Inc. and Ypsomed AG are focusing on the development of user-friendly delivery devices that enhance the vaccination experience for patients and healthcare providers alike. These firms are placing an emphasis on combining convenience with safety, thus appealing to the growing trend of self-administration in vaccine delivery. As competition intensifies, companies that prioritize customer-centric innovations and adapt to evolving market demands are more likely to thrive in this dynamic environment.

Moreover, partnerships and collaborations are becoming increasingly common in the competitive landscape of the COVID-19 vaccine packaging market. Many manufacturers are seeking alliances with pharmaceutical companies, healthcare providers, and technology firms to leverage complementary strengths and drive product development. Collaborations can lead to the creation of integrated solutions that optimize the entire vaccine distribution process, resulting in more efficient and effective vaccination campaigns. As the market continues to evolve, companies that foster strategic partnerships and focus on innovation will be well-positioned to capitalize on emerging opportunities and navigate the challenges of the COVID-19 vaccine packaging and delivery devices market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Schott AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 3M Company
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Ypsomed AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Medtronic plc
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Gerresheimer AG
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 AptarGroup, Inc.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Hoffmann-La Roche AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Siemens Healthineers
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Cardinal Health, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Polymer Solutions Group
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Roxane Laboratories, Inc.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Becton, Dickinson and Company
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Fujifilm Diosynth Biotechnologies
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 West Pharmaceutical Services, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Vetter Pharma-Fertigung GmbH & Co. KG
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 COVID-19 Vaccine Packaging And Delivery Devices Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Vaccination Centers
    • 6.1.4 Retail Pharmacies
    • 6.1.5 Others
  • 6.2 COVID-19 Vaccine Packaging And Delivery Devices Market, By Product Type
    • 6.2.1 Vials
    • 6.2.2 Syringes
    • 6.2.3 Ampoules
    • 6.2.4 Cartridges
    • 6.2.5 Prefilled Pens
  • 6.3 COVID-19 Vaccine Packaging And Delivery Devices Market, By Material Type
    • 6.3.1 Glass
    • 6.3.2 Plastic
    • 6.3.3 Metal
    • 6.3.4 Rubber
    • 6.3.5 Others
  • 6.4 COVID-19 Vaccine Packaging And Delivery Devices Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 COVID-19 Vaccine Packaging And Delivery Devices Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global COVID-19 Vaccine Packaging And Delivery Devices market is categorized based on

By Product Type

• Vials
• Syringes
• Ampoules
• Cartridges
• Prefilled Pens

By Application

• Hospitals
• Clinics
• Vaccination Centers
• Retail Pharmacies
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales

By Material Type

• Glass
• Plastic
• Metal
• Rubber
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Gerresheimer AG
• Schott AG
• Becton, Dickinson and Company
• West Pharmaceutical Services, Inc.
• Siemens Healthineers
• Medtronic plc
• 3M Company
• Cardinal Health, Inc.
• Fujifilm Diosynth Biotechnologies
• Polymer Solutions Group
• AptarGroup, Inc.
• Vetter Pharma-Fertigung GmbH & Co. KG
• Ypsomed AG
• Roxane Laboratories, Inc.
• Hoffmann-La Roche AG